Latest Juvenile Diabetes Research Foundation Stories
SmartCells, a provider of polymer-based dosing technology, and the Juvenile Diabetes Research Foundation have announced a partnership to advance SmartCells's SmartInsulin for the treatment of type 1 diabetes.
SmartCells, Inc. and the Juvenile Diabetes Research Foundation (JDRF) today announced a partnership to advance SmartCells' SmartInsulin(TM) for the treatment of type 1 diabetes. SmartInsulin will be a once-a-day, glucose-regulated subcutaneous insulin formulation for treating diabetes.
Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.
Sisters Hannah and Emma Fullalove have taken part in a sponsored walk at Saltram to raise money for the Juvenile Diabetes Research Foundation.
Vishal Bhagat was a former student at the University of Texas and suffered from juvenile diabetes. A cause near to his heart, Vishal understood diabetes affects millions of children around the world.
Research and Markets (http://www.researchandmarkets.com/research/06345f/diabetics_attitud) has announced the addition of the "Diabetics: Attitudes and Behaviors in the United States 2008" report to their offering.
A U.S. study has determined type 1 diabetes patients using continuous glucose monitoring improved their HbA1c blood sugar control levels.
New study data presented by the Juvenile Diabetes Research Foundation (JDRF) today at the 44th annual meeting of the European Association for the Study of Diabetes (EASD), showed the use of Continuous Glucose Monitoring (CGM) to be effective in the management of Type 1 Diabetes.
Results of the largest ever Continuous Glucose Monitoring (CGM) study were published online today by the New England Journal of Medicine.
- To give a box on the ear to.